Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Arterial Diseases | Research article

MIF -173G/C (rs755622) polymorphism modulates coronary artery disease risk: evidence from a systematic meta-analysis

Authors: De-Yang Li, Jin-Yu Zhang, Qing-Jie Chen, Fen Liu, Qian Zhao, Xiao-Ming Gao, Xiao-Mei Li, Yi-Ning Yang

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Coronary artery disease (CAD) remains one of the major causes of death in humans. Genetic testing may allow early detection and prevention of this disease. This study aimed to investigate the association between the macrophage migration inhibitory factor (MIF) -173G/C (rs755622) polymorphism and susceptibility to CAD based on a meta-analysis.

Methods

We searched several databases to identify observational case-control studies investigating the association between the MIF -173G > C (rs755622) polymorphism and CAD risk published before July 30, 2019. Data were analyzed using the STATA software.

Results

Six studies, comprising a total of 1172 CAD cases and 1564 controls evaluated for MIF polymorphisms, were included. The occurrence of CAD was found to be associated with the C allele of the MIF rs755622 SNP in the total population (C/G, OR = 1.489, 95% CI = 1.223–1.813). Further, MIF –173G/C polymorphism was significantly associated with CAD under the allelic model in the Asian (C/G, OR = 1.775, 95% CI = 1.365–2.309) and Caucasian (C/G, OR = 1.288, 95% CI 1.003–1.654) subgroups. The data showed that the risk of CAD was higher in the population carrying the C allele.

Conclusions

We found evidence of associations between MIF -173C/G and CAD susceptibility in the Asian and Caucasian populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen Z, Sakuma M, Zago AC, Zhang X, Shi C, Leng L, Mizue Y, Bucala R, Simon D. Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24(4):709–14.CrossRef Chen Z, Sakuma M, Zago AC, Zhang X, Shi C, Leng L, Mizue Y, Bucala R, Simon D. Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24(4):709–14.CrossRef
2.
go back to reference Su SA, Ma H, Shen L, Xiang MX, Wang JA. Interleukin-17 and acute coronary syndrome. J Zhejiang Univ Sci B. 2013;14(8):664–9.CrossRef Su SA, Ma H, Shen L, Xiang MX, Wang JA. Interleukin-17 and acute coronary syndrome. J Zhejiang Univ Sci B. 2013;14(8):664–9.CrossRef
3.
go back to reference Jednacz E, Rutkowska-Sak L. Atherosclerosis in juvenile idiopathic arthritis. Mediat Inflamm. 2012;2012:714732.CrossRef Jednacz E, Rutkowska-Sak L. Atherosclerosis in juvenile idiopathic arthritis. Mediat Inflamm. 2012;2012:714732.CrossRef
4.
go back to reference Leng L, Bucala R. Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor. Cell Res. 2006;16(2):162–8.CrossRef Leng L, Bucala R. Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor. Cell Res. 2006;16(2):162–8.CrossRef
5.
go back to reference Filippatos G, Parissis JT, Adamopoulos S, Kardaras F. Chemokines in cardiovascular remodeling: clinical and therapeutic implications. Curr Mol Med. 2003;3(2):139–47.CrossRef Filippatos G, Parissis JT, Adamopoulos S, Kardaras F. Chemokines in cardiovascular remodeling: clinical and therapeutic implications. Curr Mol Med. 2003;3(2):139–47.CrossRef
6.
go back to reference Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, et al. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. J Clin Endocrinol Metab. 2002;87(4):1834–40.PubMed Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, et al. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. J Clin Endocrinol Metab. 2002;87(4):1834–40.PubMed
7.
go back to reference Xia W, Zhang F, Xie C, Jiang M, Hou M. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells. Stem Cell Res Ther. 2015;6:82.CrossRef Xia W, Zhang F, Xie C, Jiang M, Hou M. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells. Stem Cell Res Ther. 2015;6:82.CrossRef
8.
go back to reference Zernecke A, Bernhagen J, Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation. 2008;117(12):1594–602.CrossRef Zernecke A, Bernhagen J, Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation. 2008;117(12):1594–602.CrossRef
9.
go back to reference Sanchez-Zamora YI, Juarez-Avelar I, Vazquez-Mendoza A, Hiriart M, Rodriguez-Sosa M. Altered macrophage and dendritic cell response in Mif−/− mice reveals a role of Mif for inflammatory-Th1 response in type 1 diabetes. J Diab Res. 2016;2016:7053963. Sanchez-Zamora YI, Juarez-Avelar I, Vazquez-Mendoza A, Hiriart M, Rodriguez-Sosa M. Altered macrophage and dendritic cell response in Mif−/− mice reveals a role of Mif for inflammatory-Th1 response in type 1 diabetes. J Diab Res. 2016;2016:7053963.
10.
go back to reference Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 2002;3(3):170–6.CrossRef Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 2002;3(3):170–6.CrossRef
11.
go back to reference Bernhagen J, Calandra T, Bucala R. The emerging role of MIF in septic shock and infection. Biotherapy. 1994;8(2):123–7.CrossRef Bernhagen J, Calandra T, Bucala R. The emerging role of MIF in septic shock and infection. Biotherapy. 1994;8(2):123–7.CrossRef
12.
go back to reference Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, Villanueva-Quintero GD, Padilla-Gutierrez JR, Valle Y, Parra-Rojas I, Rangel-Villalobos H, Gutierrez-Urena SR, Munoz-Valle JF. Macrophage migration inhibitory factor (MIF) promoter polymorphisms (−794 CATT5-8 and −173 G>C): association with MIF and TNFalpha in psoriatic arthritis. Int J Clin Exp Med. 2014;7(9):2605–14.PubMedPubMedCentral Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, Villanueva-Quintero GD, Padilla-Gutierrez JR, Valle Y, Parra-Rojas I, Rangel-Villalobos H, Gutierrez-Urena SR, Munoz-Valle JF. Macrophage migration inhibitory factor (MIF) promoter polymorphisms (−794 CATT5-8 and −173 G>C): association with MIF and TNFalpha in psoriatic arthritis. Int J Clin Exp Med. 2014;7(9):2605–14.PubMedPubMedCentral
13.
go back to reference Budarf M, McDonald T, Sellinger B, Kozak C, Graham C, Wistow G. Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2. Genomics. 1997;39(2):235–6.CrossRef Budarf M, McDonald T, Sellinger B, Kozak C, Graham C, Wistow G. Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2. Genomics. 1997;39(2):235–6.CrossRef
14.
go back to reference Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46(9):2402–9.CrossRef Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46(9):2402–9.CrossRef
15.
go back to reference Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D. Methods work group TUSPSTF: current methods of the US preventive services task force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21–35.CrossRef Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D. Methods work group TUSPSTF: current methods of the US preventive services task force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21–35.CrossRef
16.
go back to reference Qian L, Yin RP. Macrophage Migration Inhibitory Factor Promoter Polymorphisms (−173 G>C) : Relationship with Coronary Atherosclerotic Disease Subjects. J Med Res. 2018;47(4):32–5. Qian L, Yin RP. Macrophage Migration Inhibitory Factor Promoter Polymorphisms (−173 G>C) : Relationship with Coronary Atherosclerotic Disease Subjects. J Med Res. 2018;47(4):32–5.
17.
go back to reference Shan ZX, Fu YH, Yu XY, Deng CY, Tan HH, Lin QX, Yu HM, Lin SG. Association of the polymorphism of macrophage migration inhibitory factor gene with coronary heart disease in Chinese population. Chin J Med Genet. 2006;23(5):548–50. Shan ZX, Fu YH, Yu XY, Deng CY, Tan HH, Lin QX, Yu HM, Lin SG. Association of the polymorphism of macrophage migration inhibitory factor gene with coronary heart disease in Chinese population. Chin J Med Genet. 2006;23(5):548–50.
18.
go back to reference Luo JY, Xu R, Li XM, Zhou Y, Zhao Q, Liu F, Chen BD, Ma YT, Gao XM, Yang YN. MIF gene polymorphism rs755622 is associated with coronary artery disease and severity of coronary lesions in a Chinese Kazakh population: a case-control study. Medicine. 2016;95(4):e2617.CrossRef Luo JY, Xu R, Li XM, Zhou Y, Zhao Q, Liu F, Chen BD, Ma YT, Gao XM, Yang YN. MIF gene polymorphism rs755622 is associated with coronary artery disease and severity of coronary lesions in a Chinese Kazakh population: a case-control study. Medicine. 2016;95(4):e2617.CrossRef
19.
go back to reference Ji K, Wang X, Li J, Lu Q, Wang G, Xue Y, Zhang S, Qian L, Wu W, Zhu Y, et al. Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease. Biomed Res Int. 2015;2015:315174.PubMedPubMedCentral Ji K, Wang X, Li J, Lu Q, Wang G, Xue Y, Zhang S, Qian L, Wu W, Zhu Y, et al. Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease. Biomed Res Int. 2015;2015:315174.PubMedPubMedCentral
20.
go back to reference Tereshchenko IP, Petrkova J, Mrazek F, Lukl J, Maksimov VN, Romaschenko AG, Voevoda MI, Petrek M. The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction. Clinica Chimica Acta. 2009;402(1–2):199–202.CrossRef Tereshchenko IP, Petrkova J, Mrazek F, Lukl J, Maksimov VN, Romaschenko AG, Voevoda MI, Petrek M. The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction. Clinica Chimica Acta. 2009;402(1–2):199–202.CrossRef
21.
go back to reference Lin B, Fu GS, Li CL, Huang H, Mao HH, Zhang P, Zhou BQ. Association of MIF - 173 gene polymorphism with coronary heart disease in Chinese cigarette smoking population. Clinical Education of General Practice. 2008;6(1):31–4. Lin B, Fu GS, Li CL, Huang H, Mao HH, Zhang P, Zhou BQ. Association of MIF - 173 gene polymorphism with coronary heart disease in Chinese cigarette smoking population. Clinical Education of General Practice. 2008;6(1):31–4.
22.
go back to reference Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. Bmj. 1997;315(7121):1533–7.CrossRef Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. Bmj. 1997;315(7121):1533–7.CrossRef
23.
go back to reference Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends in genetics : TIG. 2004;20(9):439–44.CrossRef Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends in genetics : TIG. 2004;20(9):439–44.CrossRef
24.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRef
25.
go back to reference Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. Jama. 2006;295(6):676–80.CrossRef Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. Jama. 2006;295(6):676–80.CrossRef
26.
go back to reference Schober A, Bernhagen J, Weber C. Chemokine-like functions of MIF in atherosclerosis. J Mol Med. 2008;86(7):761–70.CrossRef Schober A, Bernhagen J, Weber C. Chemokine-like functions of MIF in atherosclerosis. J Mol Med. 2008;86(7):761–70.CrossRef
27.
go back to reference Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007;13(5):587–96.CrossRef Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007;13(5):587–96.CrossRef
28.
go back to reference Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediat Inflamm. 2010;2010:610479.CrossRef Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediat Inflamm. 2010;2010:610479.CrossRef
29.
go back to reference Llamas-Covarrubias MA, Valle Y, Bucala R, Navarro-Hernandez RE, Palafox-Sanchez CA, Padilla-Gutierrez JR, Parra-Rojas I, Bernard-Medina AG, Reyes-Castillo Z, Munoz-Valle JF. Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine. 2013;61(3):759–65.CrossRef Llamas-Covarrubias MA, Valle Y, Bucala R, Navarro-Hernandez RE, Palafox-Sanchez CA, Padilla-Gutierrez JR, Parra-Rojas I, Bernard-Medina AG, Reyes-Castillo Z, Munoz-Valle JF. Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine. 2013;61(3):759–65.CrossRef
30.
go back to reference Lehmann LE, Schroeder S, Hartmann W, Dewald O, Book M, Weber SU, Schewe JC, Stuber F. A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass. Eur J Cardiothoracic Surg. 2006;30(1):59–63.CrossRef Lehmann LE, Schroeder S, Hartmann W, Dewald O, Book M, Weber SU, Schewe JC, Stuber F. A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass. Eur J Cardiothoracic Surg. 2006;30(1):59–63.CrossRef
31.
go back to reference Herder C, Illig T, Baumert J, Muller M, Klopp N, Khuseyinova N, Meisinger C, Martin S, Thorand B, Koenig W. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis. 2008;200(2):380–8.CrossRef Herder C, Illig T, Baumert J, Muller M, Klopp N, Khuseyinova N, Meisinger C, Martin S, Thorand B, Koenig W. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis. 2008;200(2):380–8.CrossRef
32.
go back to reference Yang LX, Guo RW, Qi F, Miao GH, Wang XM, Shi YK, Li MQ. Association between plasma macrophage migration inhibitory factor concentration and coronary artery lesion severity. Zhonghua Xin Xue Guan Bing Za Zhi. 2008;36(10):912–5.PubMed Yang LX, Guo RW, Qi F, Miao GH, Wang XM, Shi YK, Li MQ. Association between plasma macrophage migration inhibitory factor concentration and coronary artery lesion severity. Zhonghua Xin Xue Guan Bing Za Zhi. 2008;36(10):912–5.PubMed
33.
go back to reference Karakaya B, van Moorsel CH, van der Helm-van Mil AH, Huizinga TW, Ruven HJ, van der Vis JJ, Grutters JC. Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Lofgren's syndrome. Cytokine. 2014;69(2):272–6.CrossRef Karakaya B, van Moorsel CH, van der Helm-van Mil AH, Huizinga TW, Ruven HJ, van der Vis JJ, Grutters JC. Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Lofgren's syndrome. Cytokine. 2014;69(2):272–6.CrossRef
34.
go back to reference Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, Calandra T, Donn R, van Riel PL. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005;52(10):3020–9.CrossRef Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, Calandra T, Donn R, van Riel PL. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005;52(10):3020–9.CrossRef
35.
go back to reference Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007;50(22):2128–32.CrossRef Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007;50(22):2128–32.CrossRef
Metadata
Title
MIF -173G/C (rs755622) polymorphism modulates coronary artery disease risk: evidence from a systematic meta-analysis
Authors
De-Yang Li
Jin-Yu Zhang
Qing-Jie Chen
Fen Liu
Qian Zhao
Xiao-Ming Gao
Xiao-Mei Li
Yi-Ning Yang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01564-4

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue